Biosimilars: US FDA Education Campaign Is Non-Committal On Non-Medical Switching

 
• By Derrick Gingery

Substituting a biosimilar for a reference product is a state issue and outside agency's purview, FDA says.

FDA Biosimilar Check marks
FDA's biosimilar education campaign explains how biosimilars meet the same approval standards as their reference products. The agency tweeted this image as part of the campaign roll-out. • Source: FDA

More from Biosimilars

More from Biosimilars & Generics